tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yun Zhong, 42 are a BUY (79.25%), 11 are a HOLD (20.75%).
Analyst Yun Zhong, currently employed at WEDBUSH, carries an average stock price target met ratio of 23.19% that have a potential upside of 30.16% achieved within 104 days. Previously, Yun Zhong worked at BTIG.
Yun Zhong’s has documented 98 price targets and ratings displayed on 17 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on FOLD, Amicus Therapeutics at 06-Sep-2024.
Analyst best performing recommendations are on GRPH (GRAPHITE BIO).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 11/11/2020. The price target of $140 was fulfilled within 2 days with a profit of $5.27 (3.91%) receiving and performance score of 19.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2 years 3 months 28 days ago
(25-Oct-2022)
1/10 (10%)
$13.99 (348.88%)
848
Hold
$0.4
$0.01 (2.56%)
2 years 3 months 28 days ago
(25-Oct-2022)
1/1 (100%)
$0.01 (2.56%)
2
Hold
2 years 3 months 29 days ago
(24-Oct-2022)
0/2 (0%)
$2.73 (29.45%)
Hold
2 years 3 months 29 days ago
(24-Oct-2022)
0/1 (0%)
$7.55 (308.16%)
Hold
$11
2 years 4 months 24 days ago
(29-Sep-2022)
0/2 (0%)
$6.72 (157.01%)
Which stock is Yun Zhong is most bullish on?
What Year was the first public recommendation made by Yun Zhong?
